Skip to content

Quality of Life During a Twin Pregnancy

Evolution of the Quality of Life During a Twin Pregnancy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04353856
Acronym
QUALIGEM
Enrollment
50
Registered
2020-04-21
Start date
2020-07-07
Completion date
2021-07-02
Last updated
2022-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Twin Pregnancy

Brief summary

Quality of life has recently appeared as a component of health. Pregnancy has an impact on the quality of life of the parturient, whether through physical or psychological changes. It is common to think that quality of life is altered in the context of a twin pregnancy, but this has never been scientifically demonstrated. The hypothesis is to observe a decrease in the quality of life of pregnant women with twins at the end of pregnancy, in particular in case of a pregnancy-related pathology.

Interventions

OTHERquality of life assessment

quality of life assessment using the EQ5D questionnaire once a month

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* woman over 18 * ongoing twin pregnancy (2 live fetuses) * pregnancy \<15 weeks (weeks of gestation) completed * patient with follow-up at the Hôpital Femme Mère Enfant * person having expressed her non-opposition

Exclusion criteria

* inability to understand the information given and the questionnaire * person deprived of liberty, under guardianship

Design outcomes

Primary

MeasureTime frameDescription
Quality of life EQ5D questionnaireMonth 3Quality of life score established by the EQ5D questionnaire (EUROQOL EQ-5D-3L). The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026